Brainomix 360 e-ASPECTS
Overview
Brainomix 360 e-ASPECTS is an FDA-cleared and CE-marked decision support tool designed for the assessment of stroke signs on plain CT brain scans. It leverages machine learning algorithms to fully automate and standardize the Alberta Stroke Program Early CT Score (ASPECTS) and measures the volume of ischemic signs in milliliters. The software assesses non-contrast CT scans for signs of hypodensity, providing a ‘heat map’ to indicate detected areas of hypodensity. It automatically segments ASPECTS regions, scoring and outlining in red regions containing signs of hypodensity.
The tool is part of the broader Brainomix 360 Stroke platform, which uses state-of-the-art AI algorithms to provide real-time interpretation of brain scans, assisting doctors in guiding treatment and transfer decisions for stroke patients. It aims to maximize the clinical value of simple imaging and expand patient access to life-saving stroke treatments.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated ASPECTS score generation
- Measurement of ischemic signs volume (ml)
- Hypodensity 'heat map' visualization
- Automatic segmentation of ASPECTS regions
- Explainable AI for visual assistance
- Real-time interpretation of brain scans
- DICOM compliant image processing
- Web browser user interface for results access
- Pseudonymized email notifications for results
- Supports 15 languages
Use Cases
- Acute ischemic stroke assessment
- Guiding treatment decisions for stroke patients
- Guiding patient transfer decisions within stroke networks
- Improving physician interpretation of ASPECTS scores on non-contrast CT scans
- Identifying patients potentially eligible for thrombolysis and thrombectomy
- Supporting clinical trials for stroke
What Physicians Need to Know
Brainomix 360 e-ASPECTS serves as a valuable decision support tool, enhancing physician confidence and accuracy in ASPECTS scoring, particularly for non-stroke specialists. It can significantly expedite diagnosis, triage, and patient transfer in acute stroke care. While the software provides automated analysis and notifications, final diagnostic decisions should always be made by a trained physician reviewing full, non-compressed images on a diagnostic viewer (e.g., PACS) as per the standard of care. The tool is validated for ischemic stroke patients over 21 years old with known MCA or ICA occlusion and is not intended for primary interpretation of CT images or for use with neurological pathologies other than acute stroke, such as tumors, abscesses, hemorrhagic transformation, or hematoma.
Brainomix 360 e-ASPECTS is DICOM compliant, enabling seamless image acquisition and transfer to and from Picture Archiving and Communication Systems (PACS). Results can be viewed on PACS workstations or via a web user interface within a secure hospital network. It is an integral module of the comprehensive Brainomix 360 platform, which also includes e-CTA, e-CTP, and e-MRI modules, supporting a full range of stroke imaging needs. The software can be deployed as a cloud-based, hybrid, or locally installed solution on dedicated or virtualized hardware. Brainomix also has strategic partnerships, such as with Blackford, for broader distribution.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Contact for pricing |
| Deployment | Software is installed on a server within the hospital network. Results are accessible via a web browser user interface and pseudonymized email notifications. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
1 AI-estimated Brainomix 360 e-ASPECTS received FDA clearance in March 2023. It is cleared to assist clinicians in assessing and categorizing abnormal non-contrast CT scans of the brain, providing an automated ASPECTS score and a heatmap for visual assistance. |
| Integrations | |
| EHR | Not specified |
| Specialties | Emergency Medicine, Neurology, Radiology |
What the Web Says
Brainomix 360 e-ASPECTS is an AI-powered software designed to assist physicians in the rapid assessment of acute ischemic stroke using non-contrast CT scans. It automates the Alberta Stroke Program Early CT Score (ASPECTS) and provides visual aids like heatmaps to highlight areas of hypodensity. The software aims to improve the accuracy and consistency of stroke diagnosis, expedite treatment decisions, and ultimately enhance patient outcomes by facilitating faster triage and treatment in stroke networks.
Overall: PositiveStrengths
- Significantly improves the accuracy and consistency of ASPECTS scoring, even for expert neurologists and neuroradiologists.
- Leads to faster imaging interpretation and decision-making for stroke treatment.
- Increases physician confidence in treatment decisions and faster triaging.
- Has been associated with a reduction in door-in-door-out times and an increase in patients achieving functional independence after stroke.
- Provides automated detection of Large Vessel Occlusion (LVO) and hyperdense volumes, along with heatmaps for visual assistance.
- Offers a comprehensive suite of tools within the Brainomix 360 platform, including e-CTA and e-CTP for further stroke assessment.
- FDA-cleared and CE-marked, indicating regulatory approval and adherence to standards.
Limitations
- Not intended for primary interpretation of CT images and should only be used to assist physician evaluation.
- Only validated and cleared for use in patients aged over 21 years.
- Intended for use with specific Siemens SOMATON Definition scanners.
- Mobile images are not suitable for analysis.
- Should not be used for other conditions like hemorrhagic events and hematomas.
- Incorrect scoring could potentially result in false negatives.
- Accuracy for identifying hyperdense thrombus was lower (69.1%), mainly due to false positives.
- While highly accurate for identifying acute hemorrhage, false positives were typically caused by areas of calcification.
Based on reviews from: Practical Neurology, Brainomix, Frontiers in Neurology, accessdata.fda.gov, PubMed, Blackford Analysis, MDPI, Reddit, BioWorld, NeuroNews
Last updated: 2026-07-17
Ratings & Reviews
Rate Brainomix 360 e-ASPECTS
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Brainomix 360 e-ASPECTS.
Frequently Asked Questions
Investors who backed Brainomix 360 e-ASPECTS
Funded through the company that built this tool.
